Company intelligence / Profile preview

ALARIS Encore

Franklin Lakes, New Jersey, United States

Ownership: Private
Employees: ~70000
Development stage: Other

Overview

BD (Becton, Dickinson and Company) is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents. The Alaris Encore (often associated with the Alaris System or Alaris ET software) is a key component of their medication management portfolio, specifically within their infusion pump line. The Alaris System is a modular point-of-care platform that integrates infusion, monitoring, and clinical software to help reduce medication errors. BD acquired the Alaris brand through its acquisition of CareFusion in 2015, which had previously acquired the technology from Cardinal Health.

Therapeutic areas: OncologyNeurologyOtherMetabolic Disorders
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on ALARIS Encore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALARIS Encore.

Explore the full profile